Weekly MSK Literature Review

Monday: Pelvic Floor Muscle Strengthening and Low Back Pain

Main Points

• PFMSE significantly reduces low back pain intensity. Across 19 RCTs (926 participants), pelvic floor muscle-strengthening exercises produced a large, statistically significant reduction in pain intensity compared to controls (pooled SMD -1.261 +/- 0.213).

• Postpartum women benefit the most. The strongest treatment effect was observed in postpartum populations (SMD -1.614), followed by pregnant women (SMD -1.282), reflecting a strong lumbopelvic coupling during and after pregnancy.

• Longer, higher-quality interventions yield greater results. Meta-regression showed that more weeks of training, higher study quality, and more recent publication year were each independently associated with stronger effects.

• High heterogeneity warrants cautious interpretation. Despite a consistent direction of benefit across subgroups, I-squared exceeded 80% in all analyses, indicating substantial variability in protocols, populations, and measurement tools.

• PFMSE is a safe, accessible, non-surgical option. Given its low cost, minimal risk profile, and significant effect size, pelvic floor strengthening can be integrated into standard LBP rehabilitation without specialized equipment.

Clinical Significance

Pelvic floor muscle training is underutilized in standard LBP protocols despite consistent evidence of benefit, particularly for postpartum and pregnant patients. Clinicians managing lumbar pain in these populations should consider lumbopelvic screening and targeted pelvic floor strengthening as a first-line adjunct, not an afterthought.

Citation

Kazeminia, M., Rajati, F., & Rajati, M. (2022). The effect of pelvic floor muscle-strengthening exercises on low back pain: A systematic review and meta-analysis on randomized clinical trials. Neurological Sciences. https://doi.org/10.1007/s10072-022-06430-z

Tuesday: Diagnosis and Management of Lumbar Spinal Stenosis

Main Points

• LSS is highly prevalent and age-related. Lumbar spinal stenosis affects approximately 103 million people worldwide and 11% of older adults in the US, with prevalence rising sharply in aging populations.

• Diagnosis is clinical with imaging confirmation. Symptoms that worsen with lumbar extension (standing, walking) and improve with flexion (sitting, leaning forward) are hallmarks of neurogenic claudication. MRI or CT confirms structural stenosis when intervention is being considered.

• First-line treatment is nonoperative. Activity modification, NSAIDs, and physical therapy are the initial standard of care. Approximately one-third of patients improve, half remain stable, and 10-20% worsen over three years without surgery.

• Epidural steroid injections lack durable long-term benefit. The evidence does not support sustained improvement from ESIs for LSS, limiting their role to short-term symptom management.

• Surgery helps selected patients; fusion remains controversial. Decompressive laminectomy improves symptoms when conservative care fails. Adding fusion for concomitant spondylolisthesis shows mixed trial results and carries higher complication rates, longer hospital stays, and greater cost.

Clinical Significance

LSS management should follow a stepwise, conservative-first approach. Physical therapy remains the most defensible first-line intervention before escalating to injection or surgery, and clinicians should counsel patients that watchful waiting is appropriate given that most patients stabilize or improve. The uncertain benefit of fusion relative to its elevated risk and cost has direct implications for value-based care decision-making.

Citation

Katz, J. N., Zimmerman, Z. E., Mass, H., & Makhni, M. C. (2022). Diagnosis and management of lumbar spinal stenosis: A review. JAMA, 327(17), 1688-1699. https://doi.org/10.1001/jama.2022.5921

Wednesday: VAS vs. NRS After Lumbar Microdiscectomy

Main Points

• VAS and NRS are not interchangeable. Although correlated, the two scales measure different dimensions of pain. NRS captures immediate intensity, while VAS reflects a more multifaceted, sensory-affective pain experience.

• NRS-Leg is the strongest early indicator of surgical success. NRS-L showed the largest postoperative improvement and the strongest correlation with ODI (functional disability) improvement at one month post-microdiscectomy.

• All pain and disability measures improve after surgery. Significant reductions in NRS-L, NRS-B, VAS, ODI, PRI, and PPI were observed at one month, with continued improvement in VAS, ODI, and PRI at three months.

• VAS correlates more strongly with sensory-affective descriptors. VAS consistently showed stronger correlations with PRI and PPI across time points, indicating it captures qualitative dimensions of pain beyond simple intensity.

• Scale selection should be matched to assessment timing. NRS-L is best suited for early postoperative evaluation at one month. VAS aligns more closely with ODI and multidimensional pain experience at three months.

Clinical Significance

Clinicians and researchers measuring outcomes after spine surgery should not treat VAS and NRS as equivalent. Using NRS-Leg early and VAS at longer follow-up intervals maximizes the sensitivity of outcomes tracking. For value-based and PROM-based care models, scale selection directly affects how surgical success is measured and reported.

Citation

Bielewicz, J., Daniluk, B., & Kamieniak, P. (2022). VAS and NRS, same or different? Are visual analog scale values and numerical rating scale equally viable tools for assessing patients after microdiscectomy? Pain Research and Management, 2022, Article 5337483. https://doi.org/10.1155/2022/5337483

Thursday: The Lived Experience of Depression

Main Points

• Depression radically alters emotional life. People report being overwhelmed by guilt, despair, fear, and numbness, with a marked inability to feel pleasure, love, or connection to others.

• Loss of self and identity is a central feature. Individuals describe feeling unlike their past selves, empty, imprisoned, or disconnected from their own thoughts and actions, with some describing themselves as non-existent or a walking corpse.

• Time becomes distorted and oppressive. The past feels crushing, the present stagnant, and the future impossible, creating a sense of temporal paralysis that undermines motivation and hope.

• Depression reshapes relationships and social worlds. People struggle to communicate, feel estranged or isolated, and frequently encounter stigma. Cultural context shapes how symptoms are expressed and how suffering is understood by others.

• Recovery is nonlinear, personal, and relational. Recovery involves ambivalence and vulnerability and depends on multiple sources of support, including pharmacological, psychotherapeutic, social, and physical. People describe it as a journey, not a return to a previous self.

Clinical Significance

MSK clinicians encounter patients living with comorbid depression at high rates, particularly in chronic pain populations. Understanding depression as a transformation of lived experience, not merely a symptom checklist, supports more empathic and individualized care. Screening tools and referral pathways should reflect the multidimensional burden described in this review.

Citation

Fusar-Poli, P., Estrade, A., Stanghellini, G., Esposito, C. M., Rosfort, R., Mancini, M., Norman, P., Cullen, J., Adesina, M., Benavides Jimenez, G., da Cunha Lewin, C., Drah, E. A., Julien, M., Lamba, M., Mutura, E. M., Prawira, B., Sugianto, A., Teressa, J., White, L. A., & Maj, M. (2023). The lived experience of depression: A bottom-up review co-written by experts by experience and academics. World Psychiatry, 22(3), 352-365.

Friday: Analgesics for Acute Non-Specific Low Back Pain

Main Points

• Evidence for analgesic effectiveness is highly uncertain. Across 98 RCTs and 15,134 participants evaluating 69 medicines or combinations, most showed low or very low confidence for reducing pain intensity compared to placebo.

• A few medicines showed potential benefit, but with weak evidence. Tolperisone, aceclofenac plus tizanidine, pregabalin, and select NSAID plus muscle relaxant combinations reduced pain, but confidence in these findings remained low due to risk of bias and imprecision.

• Several medicines increased adverse events. Moderate to very low confidence evidence showed higher adverse event rates with tramadol, paracetamol plus tramadol, paracetamol plus sustained-release tramadol, and baclofen.

• Head-to-head comparisons are scarce. The network revealed major gaps in direct comparative trials, limiting certainty about which medicines are genuinely superior to others.

• Clinical guidance favors caution and non-pharmacologic first-line care. Given uncertain benefits and identifiable safety concerns, the authors recommend prioritizing non-pharmacologic interventions and using analgesics sparingly until higher-quality trials are available.

Clinical Significance

This network meta-analysis reinforces the evidence base for physical therapy as the primary first-line treatment for acute LBP. The uncertain and often unfavorable safety profile of commonly prescribed analgesics, including tramadol and combination regimens, strengthens the argument for PT-first care pathways and provides direct support for value-based models that reward conservative management.

Citation

Wewege, M. A., Bagg, M. K., Jones, M. D., Ferraro, M. C., Cashin, A. G., Rizzo, R. N. R., Leake, H. B., Hagstrom, A. D., Sharma, S., McLachlan, A. J., Maher, C. G., Day, R., Wand, B. M., O'Connell, N. E., Nikolakopolou, A., Schabrun, S., Gustin, S. M., & McAuley, J. H. (2023). Comparative effectiveness and safety of analgesic medicines for adults with acute non-specific low back pain: Systematic review and network meta-analysis. BMJ, 380, e072962.

Weekly Themes & Strategic Insights

1. Conservative Care as the Evidence-Based Default

Multiple papers this week converge on a single clinical directive: non-pharmacologic, conservative care should be the first-line intervention for spinal and MSK pain. Katz et al. demonstrate that most LSS patients remain stable or improve without surgery, and Wewege et al. show that analgesic medicines carry uncertain benefit and measurable harm. Kazeminia et al. add a low-risk, non-surgical exercise option that produces large effect sizes. Together, these studies make a strong evidence-based case for PT-first pathways.

2. Measurement Precision Matters for Outcomes Reporting

Bielewicz et al. challenge the widespread assumption that VAS and NRS are interchangeable. Their findings reveal that scale selection affects sensitivity at different recovery stages. This has direct implications for PROM-based care models, including CMS ACCESS, where accurate outcome measurement is tied to performance and reimbursement. Kazeminia et al. also note that high heterogeneity in measurement tools across exercise trials undermines pooled conclusions, reinforcing the need for standardized PROM selection.

3. Underutilized Interventions with Strong Evidence

Pelvic floor muscle strengthening for LBP remains underused in standard rehabilitation despite a pooled SMD of -1.261 across 19 RCTs (Kazeminia et al.). Similarly, Katz et al. highlight that ESIs continue to be commonly administered despite lack of evidence for durable benefit. Bridging the gap between evidence and practice represents both a quality improvement opportunity and a differentiator for technology-enabled MSK care platforms that can support protocol adherence.

4. The Psychosocial Dimension of Musculoskeletal Care

Fusar-Poli et al. provide a rich phenomenological account of depression that is directly relevant to MSK clinicians managing patients with chronic pain. The altered experience of time, self, and social connection described in this review maps closely onto the lived experience of chronic LBP and post-surgical patients. Treating the whole patient, not just the structural lesion, is not a soft recommendation; it is supported by the breadth of what patients experience beyond physical symptoms.

5. Risk Stratification Must Include Pharmacologic Safety

Wewege et al. document that tramadol-based regimens and baclofen are associated with elevated adverse event rates, even in acute LBP. For care coordination models and value-based payers, this has implications for medication reconciliation protocols and opioid stewardship. PT-integrated platforms with intake screening and medication tracking capabilities are well-positioned to flag these risks early in the episode of care.

6. Surgical Decision-Making Requires Patient-Centered Evidence Framing

Katz et al. demonstrate that decompression improves outcomes for carefully selected LSS patients, but the added benefit of fusion over decompression alone is not clearly established and comes with significant cost and complication risk. For MSK care systems, this reinforces the importance of shared decision-making tools and outcome data at the point of surgical referral, allowing patients and providers to weigh tradeoffs using real-world evidence rather than default assumptions about what additional intervention adds.

Implications for MSK Care Delivery, Technology, and Strategy

• PT-First Pathways: The convergence of evidence across spinal stenosis, acute LBP analgesics, and pelvic floor training supports building payer and employer benefit designs that default to PT before imaging, injection, or pharmacology.

• PROM Selection and Timing: Platforms collecting outcomes data should align scale selection with assessment timing. NRS-Leg is most sensitive at 30 days post-spine surgery; VAS captures multidimensional experience better at 90 days.

• Pelvic Floor Integration: LBP protocols for postpartum and pregnant patients should incorporate lumbopelvic screening and PFMSE as a standard adjunct given the strong evidence base and low implementation cost.

• Medication Risk Flagging: Care coordination and intake workflows should include medication screening to identify patients on tramadol combinations or baclofen for acute LBP, creating an opportunity for PT-first substitution.

• Behavioral Health Screening: Given the multidimensional lived experience of depression and its overlap with chronic MSK pain, validated screening tools should be embedded in care pathways, particularly for patients with prolonged symptom duration.

• Surgical Value Analysis: For LSS patients being referred to surgery, platforms and care coordinators should support evidence framing that distinguishes between decompression-only and fusion, given the unclear added value and significantly higher cost of fusion.

Bottom line: This week's evidence consistently points toward conservative, non-pharmacologic, patient-centered care as the default for MSK conditions. Physical therapy, targeted exercise, and rigorous outcomes measurement are not supplementary options; they are the most defensible first-line interventions across spinal stenosis, acute LBP, postpartum pain, and spine surgery recovery.